|Economy||Measure Code||Measure||Currency Code||Amount (Local)||Amount (USD)||Source||Post Date||Details|
|European Central Bank||05||05 - Health and income support||EUR|
|European Central Bank||05A||05A - Health support||EUR|
|European Central Bank||05B||05B - Income support||EUR|
|European Central Bank||05B1||05B1 - Tax and contribution deferrals and policy changes||EUR|
|European Central Bank||05B2||05B2 - Tax and contribution rates reduction||EUR|
|European Central Bank||05B3||05B3 - Subsidies to individuals and households||EUR|
|European Central Bank||05B4||05B4 - Subsidies to businesses||EUR|
|European Central Bank||05B5||05B5 - Indirect income support||EUR|
|European Central Bank||05B6||05B6 - No breakdown (income support)||EUR|
|European Central Bank||05C||05C - No breakdown (health and income support)||EUR|
|European Union||05||05 - Health and income support||EUR||16,671,000,000||18,441,371,681|
|European Union||05A||05A - Health support||EUR||11,544,000,000||12,769,911,504||OECD. http://www.oecd.org/coronavirus/en/#country-tracker (accessed 15 April 2020); EC. https://www.consilium.europa.eu/en/press/press-releases/2020/09/11/addressing-covid-19-council-approves-6-2-billion-budget-increase-for-2020/ (accessed 12 September 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1671 (accessed 21 September 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1680 (accessed 21 September 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1416 (accessed 1 August 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1829 (accessed 10 October 2020); EIB. https://www.eib.org/en/press/all/2020-271-covid-19-eib-provides-eur50-million-to-navarre-to-strengthen-its-health-response-to-covid-19 (accessed 15 October 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_2041 (accessed 20 January 2021); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_2136 (accessed 21 November 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_2200 (accessed 28 November 2020); Council of the EU. https://www.consilium.europa.eu/en/press/press-releases/2020/12/07/council-greenlights-temporary-vat-relief-on-covid-19-vaccines-and-test-kits/ (accessed 7 December 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_21_50 (accessed 15 January 2021); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_21_51 (accessed 20 January 2021); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_21_655 (accessed 18 February 2021). EC. https://ec.europa.eu/commission/presscorner/detail/en/statement_21_861 (accessed 27 February 2021). European Council. https://www.consilium.europa.eu/en/press/press-releases/2021/02/25/statement-of-the-members-of-the-european-council-on-covid-19-and-health-25-february-2021/ (accessed 27 February 2021).||
(i) 13 March 2020, EUR800 million of the EU Solidarity Fund will be available by including a public health crisis within its scope, with a view of mobilizing it if needed for the hardest-hit EU member states; (ii) 19 March 2020, The European Commission (EC) decided to create a European civil protection stockpile of medical equipment (initial budget of EUR50 million, proposed to increase to EUR80 million) with a 90% Commission grant; (iii) 2 April 2020, The EC presented legislative proposals for an Emergency Support Instrument for the healthcare sector, (EUR3 billion) from the EU budget. 11 September 2020, The EC agreed to add EUR6.2 billion to the EU 2020 budget to address the impact of the COVID-19-crisis and to fund inter alia the vaccine strategy. The revised budget increases payments for the Emergency Support Instrument (ESI) by EUR1.09 billion to ensure the development and deployment of a COVID-19 vaccine. The Commission will use this money as a down-payment for pre-ordering vaccine doses. 18 September 2020, EU allocates EUR150 million for the transport of essential medical items through the ESI and entered into a contract with Sanofi-GSK to purchase up to 300 million doses of the Sanofi-GSK vaccine; (iv) EUR63 million, EC secures EU access to Remdesivir (first European treatment authorized for COVID-19); (v) No amount/estimate: 8 October 2020, the EC approved a third contract with a pharmaceutical company, Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson. Once the vaccine has proven to be safe and effective against COVID-19, the contract allows EU Member States to purchase vaccines for 200 million people. They will also have the possibility to purchase vaccines for an additional 200 million people; (vi) 13 October 2020, EIB is providing EUR50 million to the Autonomous Community of Navarre, Spain to strengthen its capacity to respond to the COVID-19 health crisis. The EU bank financing will enable the Spanish region to adapt its healthcare infrastructure to meet the additional costs generated by the pandemic; (vii) No amount/estimate: 11 November 2020, In order to step up the fight against the COVID-19 pandemic and future health emergencies, The EC is taking the first steps towards building the European Health Union. The Commission is putting forward a set of proposals to strengthen the EU's health security framework, and to reinforce the crisis preparedness and response role of key EU agencies; (viii) No amount/estimate: 17 November 2020, The EC approves a fifth contract with CureVac for the initial purchase of 225 million doses of potential vaccine; (ix) No amount/estimate: 25 November 2020, The EC approved a sixth contract under the EU Vaccines Strategy, with the pharmaceutical company Moderna. The contract provides for the initial purchase of 80 million doses on behalf of all EU Member States; (x) 7 December 2020: The Council of Europe adopted amendments to the directive on the common system of value added tax (VAT) to allow member states to temporarily exempt COVID-19 vaccines and testing kits, as well as closely related services, from VAT; (xi) 11 January 2021, The EC supports blood services to increase COVID-19 convalescent plasma collection with grants amounting to EUR36 million financed through the ESI; (xii) No amount/estimate: 12 January 2020, The EC concluded exploratory talks with the pharmaceutical company Valneva with a view to purchasing its potential vaccine against COVID-19. The envisaged contract with Valneva would provide for the possibility for all EU Member States to purchase together 30 million doses, and they could further purchase up to 30 million more doses; (xiii) No amount/estimate: 17 February 2021, The EC approves second contract with Moderna to ensure up to additional 300 million doses; (xiv) 25 February 2021, EUR225million for the HERA (Health Emergency Preparedness and Response Authority) Incubator, Europe’s bio-defense preparedness plan against COVID-19 variants (for details on the HERA Incubator, see: http://bit.ly/37qanXl). The plan received strong support from leaders of the Member States [update].
|European Union||05B||05B - Income support||EUR||327,000,000||361,725,664|
|European Union||05B1||05B1 - Tax and contribution deferrals and policy changes||EUR|
|European Union||05B2||05B2 - Tax and contribution rates reduction||EUR|
|European Union||05B3||05B3 - Subsidies to individuals and households||EUR||179,000,000||198,008,850||OECD. http://www.oecd.org/coronavirus/en/#country-tracker (accessed 15 April 2020).||
Mobilized European Globalisation Adjustment Fund to support dismissed workers and those self-employed (up to EUR179 million available in 2020).
|European Union||05B4||05B4 - Subsidies to businesses||EUR||148,000,000||163,716,814||OECD. http://www.oecd.org/coronavirus/en/#country-tracker (accessed 15 April 2020); IMF. https://www.imf.org/en/Topics/imf-and-covid19/Policy-Responses-to-COVID-19 (accessed 21 May 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1221 (accessed 9 July 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1872 (accessed 15 October 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1007 (accessed 12 June 2020).||
(i) No amount/estimate: 19 March 2020, EU Commission intends to allow State aid for struggling businesses and enable Member States to use the full flexibility foreseen under State aid rules. On 8 May 2020, the European Commission adopted a second amendment to extend the scope of the State aid Temporary Framework to recapitalization and subordinated debt measures to further support the economy in the context of the coronavirus outbreak. The amended Temporary Framework will be in place until the end of December 2020, except for recapitalization measures which has an extended period by the end of June 2021. The Commission will assess before these dates if they need to be extended. 29 June 2020, third amendment to the State aid extends Temporary Framework to enable Member States to provide public support under the Temporary Framework to all micro and small companies, even if they were already in financial difficulty on 31 December 2019; 13 October 2020, EC has decided to prolong and extend the scope of the State aid Temporary Framework adopted on 19 March 2020 to support the economy in the context of the coronavirus outbreak. All sections of the Temporary Framework are prolonged for six months until 30 June 2021, and the section to enable recapitalization support is prolonged for three months until 30 September 2021; (ii) 8 June 2020, European Innovation Council (EIC) Accelerator Pilot fund issued grants of EUR148 million to innovative companies.
|European Union||05B5||05B5 - Indirect income support||EUR|
|European Union||05B6||05B6 - No breakdown (income support)||EUR|
|European Union||05C||05C - No breakdown (health and income support)||EUR||4,800,000,000||5,309,734,513||EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_997 (accessed 12 June 2020); ESF. https://esf.ie/en/covid-19/react-eu/ (accessed 5 September 2020).||
(i) June 2020, EUR4.8 billion (in grants from the amended 2020 annual EU budget) for REACT-EU that will provide additional funding for the most important sectors that will be crucial to lay the basis for a sound recovery. This will involve investment to support job maintenance, including through short-time work schemes and support for the self-employed. The funds can also be used to support job creation and youth employment measures, to health care systems and the provision of working capital and investment support for small and medium-sized enterprises. Such support will be available across economic sectors, including for the much-affected tourism and culture sectors. The additional support will also serve to invest in the European Green Deal and digital transition, as an enhancement to the significant investment in those areas that is already taking place through EU cohesion policy.
|Pakistan||05||05 - Health and income support||PKR||1,466,251,005,000||8,836,419,856|
|Pakistan||05A||05A - Health support||PKR||24,943,005,000||150,320,009||IMF. https://www.imf.org/en/Topics/imf-and-covid19/Policy-Responses-to-COVID-19 (accessed 8 & 15 May, 24 June 2020), 4 January 2021); Government of Pakistan, Finance Division. http://www.finance.gov.pk/press_releases.html (accessed 12 June 2020); Reuters. https://www.reuters.com/article/health-coronavirus-pakistan-vaccine/pakistan-approves-initial-funds-to-purchase-covid-19-vaccine-idUSL8N2IH3HC (accessed 13 December 2020); Reuters. https://www.reuters.com/article/us-health-coronavirus-pakistan-vaccine/pakistan-to-purchase-1-2-million-covid-19-vaccine-doses-from-chinas-sinopharm-idUSKBN2950DQ (accessed 8 January 2021); Mint. https://www.livemint.com/news/world/pakistan-secures-17-million-doses-of-astrazeneca-vaccine-through-covax-11612023889389.html (accessed 1 February 2021); The Hindu Business Line.https://www.thehindubusinessline.com/news/world/pakistan-to-start-covid-19-vaccination-drive-next-week/article33681791.ece# (accessed 29 January 2021); Dawn. https://www.dawn.com/news/1602228/chinese-pharma-sinopharms-covid-vaccine-becomes-2nd-to-be-approved-for-emergency-use-in-pakistan (accessed 21 January 2021); Khaleej Times. https://www.khaleejtimes.com/coronavirus-pandemic/covid-19-pakistan-approves-emergency-use-of-russias-sputnik-v-vaccine (accessed 25 January 2021); Reuters. https://www.reuters.com/article/us-health-coronavirus-pakistan-vaccine/pakistan-approves-chinese-cansinobio-covid-vaccine-for-emergency-use-idUSKBN2AC1FG (accessed 15 February 2021); Reuters. https://www.reuters.com/article/us-health-coronavirus-pakistan-vaccine/pakistan-to-receive-2-8-million-doses-of-astrazeneca-vaccine-under-covax-scheme-on-march-2-idUSKBN2AI1QU (accessed 19 February 2021).||
(i) 10 June 2020, The Economic Coordination Committee (ECC) approved an amount of PKR480.566 million to cover the risk allowance of health care workers performing duties related to COVID-19. This is already part of the fiscal stimulus package dated 24 March 2020; (ii) 2 December 2020, USD150 million was approved to buy COVID-19 vaccines, initially to cover the most vulnerable 5% of the population. 31 December 2020, Pakistan will purchase 1.2 million COVID-19 vaccine doses from China’s Sinopharm. 28 January 2021, The government announced that it would begin its COVID-19 vaccination drive in February. 30 January 2021, Pakistan secured 17 million doses of AstraZeneca vaccine through COVAX,a sharing scheme coordinated by the World Health Organization to suppport low-income countries. 18 January 2021, The Drug Regulatory Authority of Pakistan approved for emergency use the COVID-19 vaccines of Oxford University-AstraZeneca and Sinopharm. 24 January 2021, Sputnik V is the third vaccine to be approved for the emergency use in the country. 12 February 2021, Pakistan approved China’s CanSino Biologics Inc.’s (CanSinoBIO) COVID-19 vaccine for emergency used, the fourth candidate authorized in the country. 18 February 2021, The government issued guidelines for private companies to set up centers to administer COVID-19 vaccines; (iii) 16 December 2020, PKR53.10 million for procurement of medical equipment, machinery, and medicines to combat COVID-19; (iv) No amount/estimate: 24 December 2020, The ECC approved the duty and tax free import of cryogenic oxygen tanks for better handling of COVID-19 situation.
|Pakistan||05B||05B - Income support||PKR||1,256,308,000,000||7,571,190,007|
|Pakistan||05B1||05B1 - Tax and contribution deferrals and policy changes||PKR|
|Pakistan||05B2||05B2 - Tax and contribution rates reduction||PKR||100,000,000,000||602,653,968||IMF. https://www.imf.org/en/Topics/imf-and-covid19/Policy-Responses-to-COVID-19 (accessed 8 & 15 May, 24 June 2020).||
24 March 2020, The relief package includes PKR100 billion accelerated tax refunds to the export industry.
|Pakistan||05B3||05B3 - Subsidies to individuals and households||PKR||560,000,000,000||3,374,862,218||IMF. https://www.imf.org/en/Topics/imf-and-covid19/Policy-Responses-to-COVID-19 (accessed 8 & 15 May, 24 June 2020, 8 January 2021); Government of Pakistan, Finance Division. http://www.finance.gov.pk/press_releases.html (accessed 12 June 2020, 19 February).||
(i) 24 March 2020, a relief package including: (a) PKR200 billion relief to daily wage workers, including PKR75 billion of approved cash disbursements to 6.2 million workers; (b) PKR150 billion in cash transfers to 12 million low-income families; (c) PKR70 billion, relief in fuel prices; (d) PKR110 billion, electricity bill payments relief; (ii) June 2020, PKR50 billion agriculture package for farmers and crop growers, likely consisting of reduction of electricity tariff for tube-wells, reduction of import duty on fertilizers, reduction of mark-up and waiver of agricultural loans, and deregulation of the import and export of agricultural products and livestock. This is already part of the fiscal stimulus package dated 24 March 2020; (iii) 18 June 2020, The FY 2021 budget includes a housing package to subsidize mortgages (PKR30 billion); (iv) No amount/estimate: 28 January 2021, The Economic Coordination Committee considered and approved the first proposal regarding continuation of general subsidy on five essential items through Utility Stores Corporation from 1 January 2021 to 30 June 2021 out of funds allocated under Prime Minister’s Relief Package-2020 in the backdrop of COVID-19 pandemic.
|Pakistan||05B4||05B4 - Subsidies to businesses||PKR||50,000,000,000||301,326,984||IMF. https://www.imf.org/en/Topics/imf-and-covid19/Policy-Responses-to-COVID-19 (accessed 8 & 15 May, 24 June 2020).||
24 March 2020, The relief package includes PKR50 billion financial support to utility stores.
|Pakistan||05B5||05B5 - Indirect income support||PKR||446,308,000,000||2,689,692,869||IMF. https://www.imf.org/en/Topics/imf-and-covid19/Policy-Responses-to-COVID-19 (accessed 8 & 15 May, 24 June 2020); Government of Pakistan, Finance Division. http://www.finance.gov.pk/press_releases.html (accessed 12 June 2020), 19 February 2021).||
(i) 24 March 2020, a relief package including: (a) PKR280 billion, resources for an accelerated procurement of wheat; (b) PKR25 billion, transfer to the National Disaster Management Authority (NDMA) for the purchase of necessary equipment to deal with the pandemic; (ii) 3 February 2021, The Economic Coordination Committee approved PKR141.308 million technical supplementary grants to the Ministry of Information and Broadcasting for an expenditure incurred on media campaigns to create awareness among the public during the COVID-19 pandemic.
|Pakistan||05B6||05B6 - No breakdown (income support)||PKR||100,000,000,000||602,653,968||IMF. https://www.imf.org/en/Topics/imf-and-covid19/Policy-Responses-to-COVID-19 (accessed 8 & 15 May, 24 June 2020).||
24 March 2020, The relief package includes PKR100 billion financial support to SMEs, in the form of relief on electricity bill payments, bank lending support, and subsidies and tax incentives.
|Pakistan||05C||05C - No breakdown (health and income support)||PKR||185,000,000,000||1,114,909,840||IMF. https://www.imf.org/en/Topics/imf-and-covid19/Policy-Responses-to-COVID-19 (accessed 8 & 15 May, 24 June 2020); Government of Pakistan, Finance Division. http://www.finance.gov.pk/press_releases.html (accessed 12 June 2020).||
(i) 24 March 2020, a relief package including: (a) PKR100 billion, emergency contingency fund; (b) PKR15 billion total support for health and food supplies; (ii) 18 June 2020, The FY 2021 budget includes further tariff and custom duty reductions on food items and a PKR70 billion allocation for ‘COVID-19 Responsive and Other Natural Calamities Control Program’, as well as the provision of tax incentives to the construction sector to address the acute employment needs generated by the lockdowns.
|Turkmenistan||05||05 - Health and income support||TMT|
|Turkmenistan||05A||05A - Health support||TMT||IMF. https://www.imf.org/en/Topics/imf-and-covid19/Policy-Responses-to-COVID-19 (accessed 11 November 2020).||
(i) No amount/estimate: The Government announced that a bonus salary of 20%, 15%, and 10% will be given to healthcare professionals working in the remote rural facilities, frontline facilities, and other rural facilities, respectively.
|Turkmenistan||05B||05B - Income support||TMT|
|Turkmenistan||05B1||05B1 - Tax and contribution deferrals and policy changes||TMT|
|Turkmenistan||05B2||05B2 - Tax and contribution rates reduction||TMT|
|Turkmenistan||05B3||05B3 - Subsidies to individuals and households||TMT|
|Turkmenistan||05B4||05B4 - Subsidies to businesses||TMT|
|Turkmenistan||05B5||05B5 - Indirect income support||TMT|
|Turkmenistan||05B6||05B6 - No breakdown (income support)||TMT|
|Turkmenistan||05C||05C - No breakdown (health and income support)||TMT|
|European Central Bank||05||05 - Health and income support||EUR|
|European Central Bank||05A||05A - Health support||EUR|